1.Turkcapar N, Demir O, Atli T, et al. Late onset rheumatoid arthritis: clinical and laboratory comparisons with younger onset patients. Arch Gerontol Geriatr 2006;42:225-31.
2. Inoue K, Shichikawa K, Nishioka J, et al. Older age onset rheumatoid arthritis with or without osteoarthritis. Ann Rheum Dis 1987;46:908-11.
3.Naschitz JE, Rosner I. Musculoskeletal syndromes associated with malignancy (excluding hypertrophic osteoarthropathy). Curr Opin Rheumatol 2008;20-100.
4.Shah AA, Casciola-Rosen L, Rosen A. Review: cancer-induced autoimmunity in the rheumatic diseases. Arthritis Rheumatol 2015;67-317.
5. SchmalzingM.Paraneoplastic syndromes in rheumatology.2018;77:309-321.
6.Mito K, Maruyama R, Uenishi Y, Arita K, et al. Hypertrophic pulmonary osteoarthropathy associated with non-small cell lung cancer demonstrated growth hormone-releasing hormone by immunohistochemical analysis. Intern Med 2001;40:532-5.
7.Majithia V, Peel C, Geraci SA. Rheumatoid arthritis in elderly patients. Geriatrics 2009;64:22-8.
8.Maoz CR, Langevitz P, Livneh A, et al. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum 1998;27:319-24.
9.Cherin P, Piette JC, Herson S, et al. Dermatomyositis and ovarian cancer: a report of 7 cases and literature review. J Rheumatol 1993;20:1897-9.
10.Caldwell DS, McCallum RM. Rheumatologic manifestations of cancer. Med Clin North Am 1986;70:385-417.
11.Forbes AM, Woodrow JC, Verbov JL, et al. Carcinoma of breast and scleroderma: four further cases and a literature review. Br J Rheumatol 1989;28:65-9.
12.Greer JM, Longley S, Edwards NL, et al. Vasculitis associated with malignancy. Experience with 13 patients and literatüre. Medicine (Baltimore). 1988;67:220-30.
13.KeaneJ,Gershon S,Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;11:1098-104
Geç başlangıçlı romatoid artrit ve akciğer kanseri birlikteliği
Year 2019,
Volume: 44 Issue: 4, 1543 - 1545, 29.12.2019
1.Turkcapar N, Demir O, Atli T, et al. Late onset rheumatoid arthritis: clinical and laboratory comparisons with younger onset patients. Arch Gerontol Geriatr 2006;42:225-31.
2. Inoue K, Shichikawa K, Nishioka J, et al. Older age onset rheumatoid arthritis with or without osteoarthritis. Ann Rheum Dis 1987;46:908-11.
3.Naschitz JE, Rosner I. Musculoskeletal syndromes associated with malignancy (excluding hypertrophic osteoarthropathy). Curr Opin Rheumatol 2008;20-100.
4.Shah AA, Casciola-Rosen L, Rosen A. Review: cancer-induced autoimmunity in the rheumatic diseases. Arthritis Rheumatol 2015;67-317.
5. SchmalzingM.Paraneoplastic syndromes in rheumatology.2018;77:309-321.
6.Mito K, Maruyama R, Uenishi Y, Arita K, et al. Hypertrophic pulmonary osteoarthropathy associated with non-small cell lung cancer demonstrated growth hormone-releasing hormone by immunohistochemical analysis. Intern Med 2001;40:532-5.
7.Majithia V, Peel C, Geraci SA. Rheumatoid arthritis in elderly patients. Geriatrics 2009;64:22-8.
8.Maoz CR, Langevitz P, Livneh A, et al. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum 1998;27:319-24.
9.Cherin P, Piette JC, Herson S, et al. Dermatomyositis and ovarian cancer: a report of 7 cases and literature review. J Rheumatol 1993;20:1897-9.
10.Caldwell DS, McCallum RM. Rheumatologic manifestations of cancer. Med Clin North Am 1986;70:385-417.
11.Forbes AM, Woodrow JC, Verbov JL, et al. Carcinoma of breast and scleroderma: four further cases and a literature review. Br J Rheumatol 1989;28:65-9.
12.Greer JM, Longley S, Edwards NL, et al. Vasculitis associated with malignancy. Experience with 13 patients and literatüre. Medicine (Baltimore). 1988;67:220-30.
13.KeaneJ,Gershon S,Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;11:1098-104
Limon, Muhammet et al. “Geç başlangıçlı Romatoid Artrit Ve akciğer Kanseri birlikteliği”. Cukurova Medical Journal, vol. 44, no. 4, 2019, pp. 1543-5, doi:10.17826/cumj.552579.